Updated:
Vansen Pharma Inc.
Vansen Pharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001378076, and its reported industry is...
Overview
Vansen Pharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001378076, and its reported industry is Gold and Silver Ores. In 10-K filed on 2013-04-12, it reported net income of USD -37,148; total assets of USD 15,015 for the fiscal period ended 2012-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Vansen Pharma Inc.
- Former names in filing history
- Okana Ventures, Inc. (2006-10-20 to 2013-08-19)
- Classification
- Company
- Industry (SIC)
- 1040 — Gold and Silver Ores
- Headquarters
- Vancouver, Canada
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 0001378076
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2012USD | -$37,148 | $15,015 | $15,015 | -$28,751 | |
| FY2011USD | -$25,064 | $18,766 | $18,766 | -$20,422 |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 10-K | FORM 10-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Vansen Pharma Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.